Northwestern Mutual Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-320
| Closed | -$5.93K | – | 3736 |
|
|
2023
Q3 | $5.93K | Buy |
320
+300
| +1,500% | +$3.39K | ﹤0.01% | 2704 |
|
|
2023
Q2 | $221 | Sell |
20
-54
| -73% | -$752 | ﹤0.01% | 3236 |
|
|
2023
Q1 | $994 | Buy |
74
+54
| +270% | +$934 | ﹤0.01% | 3030 |
|
|
2022
Q4 | $247 | Hold |
20
| – | – | ﹤0.01% | 3173 |
|
|
2022
Q3 | $0 | Sell |
20
-67
| -77% | -$1.08K | ﹤0.01% | 3482 |
|
|
2022
Q2 | $1K | Sell |
87
-33
| -28% | -$528 | ﹤0.01% | 3111 |
|
|
2022
Q1 | $2K | Buy |
120
+100
| +500% | +$1.57K | ﹤0.01% | 2946 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 3406 |
|
|
2021
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 3281 |
|
|
2021
Q2 | $0 | Sell |
20
-115
| -85% | -$2.28K | ﹤0.01% | 3202 |
|
|
2021
Q1 | $3K | Buy |
135
+115
| +575% | +$3.21K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $0 | Sell |
20
-119
| -86% | -$3.94K | ﹤0.01% | 2933 |
|
|
2020
Q3 | $6K | Hold |
139
| – | – | ﹤0.01% | 2153 |
|
|
2020
Q2 | $7K | Buy |
139
+119
| +595% | +$9.19K | ﹤0.01% | 2023 |
|
|
2020
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 2488 |
|
|
2019
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 2261 |
|
|
2019
Q3 | $1K | Sell |
20
-166
| -89% | -$11.1K | ﹤0.01% | 2414 |
|
|
2019
Q2 | $15K | Buy |
186
+145
| +354% | +$13K | ﹤0.01% | 1831 |
|
|
2019
Q1 | $4K | Sell |
41
-141
| -77% | -$15.4K | ﹤0.01% | 2207 |
|
|
2018
Q4 | $18K | Buy |
182
+149
| +452% | +$15.4K | ﹤0.01% | 1639 |
|
|
2018
Q3 | $5K | Sell |
33
-87
| -73% | -$9.21K | ﹤0.01% | 2120 |
|
|
2018
Q2 | $10K | Buy |
120
+33
| +38% | +$2.42K | ﹤0.01% | 1850 |
|
|
2018
Q1 | $5K | Hold |
87
| – | – | ﹤0.01% | 1926 |
|
|
2017
Q4 | $5K | Hold |
87
| – | – | ﹤0.01% | 1946 |
|
|
2017
Q3 | $5K | Buy |
+87
| New | +$9.37K | ﹤0.01% | 1832 |
|
Northwestern Mutual Wealth Management's ICPT Position: Q4 2023 in Review
Northwestern Mutual Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 320 shares — an estimated $5.93K sold.
Northwestern Mutual Wealth Management first reported a position in ICPT in Q3 2017 and held it in 25 quarters. The position peaked at $18K in Q4 2018. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Northwestern Mutual Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 320 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $5.93K.
- Northwestern Mutual Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 25 quarters.
- Northwestern Mutual Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $18K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.